Actavis v ICOS & Eli Lilly [2017] EWHC 2880 (Pat)15 February 2018Adrian Speck QC and Tom Jones appeared for Actavis, Teva and Mylan in this application by Lilly and Icos (“Lilly”) for an interim injunction to prevent the launch of generic 2.5 and 5mg tadalafil pending a petition by Lilly to the Supreme Court for permission to appeal. At first instance, Lilly’s patent for a dosing regime concerning the […]
Cantel Medical (UK) v ARC Medical Design [2018] EWHC 345 (Pat)26 January 2018Daniel Alexander QC appeared with Henry Ward for the Defendant, Arc Medical. Cantel sued Arc for a declaration of non- infringement and/ or revocation of Arc’s patents for endoscope caps which increase the detection of polyps/ adenomas. Arc applied to amend its patent and counterclaimed for infringement of its Community Registered and UK unregistered design rights. His Honour […]
Hospira v Cubist Pharmaceuticals [2018] EWCA Civ 1218 January 2018Richard Meade QC and Isabel Jamal appeared for the Respondent, Hospira, in this appeal against the revocation of Cubist’s patent at first instance. The patent concerned a method of purification for the antibiotic daptomycin. The Judge had found that the patent was obvious in light of the teaching of a piece of prior art which […]
W3 v easyGroup [2018] EWHC 7 (Ch)12 January 2018Tom Moody-Stuart QC and Jessie Bowhill were instructed in this complex trade mark dispute concerning the EASY marks which culminated in a two week High Court trial in front of Arnold J. The case involved complex issues arising out of an extensive period of concurrent trading by the parties, including the relevant date for assessment of infringement claims, […]
Burgerista Operations v UK Prosper Limited [2018] EWHC 35 (IPEC)12 January 2018Tom Jones appeared for the Claimant and Ashton Chantrielle appeared for the Defendants in this case relating to the validity and infringement of the European trade mark ‘BURGERISTA’.